Global Alpha-1 Antitrypsin Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Alpha-1 Antitrypsin Drugs Market Size was estimated at USD 1335.77 million in 2023 and is projected to reach USD 2167.24 million by 2029, exhibiting a CAGR of 8.40% during the forecast period.
This report provides a deep insight into the global Alpha-1 Antitrypsin Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alpha-1 Antitrypsin Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alpha-1 Antitrypsin Drugs market in any manner.
Global Alpha-1 Antitrypsin Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Baxter
CSL Behring
Grifols
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
Market Segmentation (by Type)
Parenteral
Inhalation
Market Segmentation (by Application)
Drugstore
Hospital
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alpha-1 Antitrypsin Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Alpha-1 Antitrypsin Drugs Market Size was estimated at USD 1335.77 million in 2023 and is projected to reach USD 2167.24 million by 2029, exhibiting a CAGR of 8.40% during the forecast period.
This report provides a deep insight into the global Alpha-1 Antitrypsin Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alpha-1 Antitrypsin Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alpha-1 Antitrypsin Drugs market in any manner.
Global Alpha-1 Antitrypsin Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Baxter
CSL Behring
Grifols
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
Market Segmentation (by Type)
Parenteral
Inhalation
Market Segmentation (by Application)
Drugstore
Hospital
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Alpha-1 Antitrypsin Drugs Market
- Overview of the regional outlook of the Alpha-1 Antitrypsin Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alpha-1 Antitrypsin Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Alpha-1 Antitrypsin Drugs
1.2 Key Market Segments
1.2.1 Alpha-1 Antitrypsin Drugs Segment by Type
1.2.2 Alpha-1 Antitrypsin Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ALPHA-1 ANTITRYPSIN DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Alpha-1 Antitrypsin Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Alpha-1 Antitrypsin Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ALPHA-1 ANTITRYPSIN DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2019-2024)
3.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Alpha-1 Antitrypsin Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Alpha-1 Antitrypsin Drugs Sales Sites, Area Served, Product Type
3.6 Alpha-1 Antitrypsin Drugs Market Competitive Situation and Trends
3.6.1 Alpha-1 Antitrypsin Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Alpha-1 Antitrypsin Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ALPHA-1 ANTITRYPSIN DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Alpha-1 Antitrypsin Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ALPHA-1 ANTITRYPSIN DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ALPHA-1 ANTITRYPSIN DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2019-2024)
6.3 Global Alpha-1 Antitrypsin Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Alpha-1 Antitrypsin Drugs Price by Type (2019-2024)
7 ALPHA-1 ANTITRYPSIN DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alpha-1 Antitrypsin Drugs Market Sales by Application (2019-2024)
7.3 Global Alpha-1 Antitrypsin Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Alpha-1 Antitrypsin Drugs Sales Growth Rate by Application (2019-2024)
8 ALPHA-1 ANTITRYPSIN DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Alpha-1 Antitrypsin Drugs Sales by Region
8.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Region
8.1.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Alpha-1 Antitrypsin Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Alpha-1 Antitrypsin Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Baxter
9.1.1 Baxter Alpha-1 Antitrypsin Drugs Basic Information
9.1.2 Baxter Alpha-1 Antitrypsin Drugs Product Overview
9.1.3 Baxter Alpha-1 Antitrypsin Drugs Product Market Performance
9.1.4 Baxter Business Overview
9.1.5 Baxter Alpha-1 Antitrypsin Drugs SWOT Analysis
9.1.6 Baxter Recent Developments
9.2 CSL Behring
9.2.1 CSL Behring Alpha-1 Antitrypsin Drugs Basic Information
9.2.2 CSL Behring Alpha-1 Antitrypsin Drugs Product Overview
9.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Product Market Performance
9.2.4 CSL Behring Business Overview
9.2.5 CSL Behring Alpha-1 Antitrypsin Drugs SWOT Analysis
9.2.6 CSL Behring Recent Developments
9.3 Grifols
9.3.1 Grifols Alpha-1 Antitrypsin Drugs Basic Information
9.3.2 Grifols Alpha-1 Antitrypsin Drugs Product Overview
9.3.3 Grifols Alpha-1 Antitrypsin Drugs Product Market Performance
9.3.4 Grifols Alpha-1 Antitrypsin Drugs SWOT Analysis
9.3.5 Grifols Business Overview
9.3.6 Grifols Recent Developments
9.4 Kamada
9.4.1 Kamada Alpha-1 Antitrypsin Drugs Basic Information
9.4.2 Kamada Alpha-1 Antitrypsin Drugs Product Overview
9.4.3 Kamada Alpha-1 Antitrypsin Drugs Product Market Performance
9.4.4 Kamada Business Overview
9.4.5 Kamada Recent Developments
9.5 Abeona Therapeutics
9.5.1 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Basic Information
9.5.2 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Overview
9.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Market Performance
9.5.4 Abeona Therapeutics Business Overview
9.5.5 Abeona Therapeutics Recent Developments
9.6 Alnylam Pharmaceuticals
9.6.1 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Basic Information
9.6.2 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Overview
9.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Market Performance
9.6.4 Alnylam Pharmaceuticals Business Overview
9.6.5 Alnylam Pharmaceuticals Recent Developments
9.7 Applied Genetic Technologies Corp
9.7.1 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Basic Information
9.7.2 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Overview
9.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Market Performance
9.7.4 Applied Genetic Technologies Corp Business Overview
9.7.5 Applied Genetic Technologies Corp Recent Developments
9.8 Arrowhead Research Corporation
9.8.1 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Basic Information
9.8.2 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Overview
9.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Market Performance
9.8.4 Arrowhead Research Corporation Business Overview
9.8.5 Arrowhead Research Corporation Recent Developments
9.9 Baxalta
9.9.1 Baxalta Alpha-1 Antitrypsin Drugs Basic Information
9.9.2 Baxalta Alpha-1 Antitrypsin Drugs Product Overview
9.9.3 Baxalta Alpha-1 Antitrypsin Drugs Product Market Performance
9.9.4 Baxalta Business Overview
9.9.5 Baxalta Recent Developments
10 ALPHA-1 ANTITRYPSIN DRUGS MARKET FORECAST BY REGION
10.1 Global Alpha-1 Antitrypsin Drugs Market Size Forecast
10.2 Global Alpha-1 Antitrypsin Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Alpha-1 Antitrypsin Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size Forecast by Region
10.2.4 South America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Alpha-1 Antitrypsin Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Alpha-1 Antitrypsin Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Alpha-1 Antitrypsin Drugs by Type (2025-2030)
11.1.2 Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Alpha-1 Antitrypsin Drugs by Type (2025-2030)
11.2 Global Alpha-1 Antitrypsin Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Alpha-1 Antitrypsin Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Alpha-1 Antitrypsin Drugs
1.2 Key Market Segments
1.2.1 Alpha-1 Antitrypsin Drugs Segment by Type
1.2.2 Alpha-1 Antitrypsin Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ALPHA-1 ANTITRYPSIN DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Alpha-1 Antitrypsin Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Alpha-1 Antitrypsin Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ALPHA-1 ANTITRYPSIN DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2019-2024)
3.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Alpha-1 Antitrypsin Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Alpha-1 Antitrypsin Drugs Sales Sites, Area Served, Product Type
3.6 Alpha-1 Antitrypsin Drugs Market Competitive Situation and Trends
3.6.1 Alpha-1 Antitrypsin Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Alpha-1 Antitrypsin Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ALPHA-1 ANTITRYPSIN DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Alpha-1 Antitrypsin Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ALPHA-1 ANTITRYPSIN DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ALPHA-1 ANTITRYPSIN DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2019-2024)
6.3 Global Alpha-1 Antitrypsin Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Alpha-1 Antitrypsin Drugs Price by Type (2019-2024)
7 ALPHA-1 ANTITRYPSIN DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alpha-1 Antitrypsin Drugs Market Sales by Application (2019-2024)
7.3 Global Alpha-1 Antitrypsin Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Alpha-1 Antitrypsin Drugs Sales Growth Rate by Application (2019-2024)
8 ALPHA-1 ANTITRYPSIN DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Alpha-1 Antitrypsin Drugs Sales by Region
8.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Region
8.1.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Alpha-1 Antitrypsin Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Alpha-1 Antitrypsin Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Baxter
9.1.1 Baxter Alpha-1 Antitrypsin Drugs Basic Information
9.1.2 Baxter Alpha-1 Antitrypsin Drugs Product Overview
9.1.3 Baxter Alpha-1 Antitrypsin Drugs Product Market Performance
9.1.4 Baxter Business Overview
9.1.5 Baxter Alpha-1 Antitrypsin Drugs SWOT Analysis
9.1.6 Baxter Recent Developments
9.2 CSL Behring
9.2.1 CSL Behring Alpha-1 Antitrypsin Drugs Basic Information
9.2.2 CSL Behring Alpha-1 Antitrypsin Drugs Product Overview
9.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Product Market Performance
9.2.4 CSL Behring Business Overview
9.2.5 CSL Behring Alpha-1 Antitrypsin Drugs SWOT Analysis
9.2.6 CSL Behring Recent Developments
9.3 Grifols
9.3.1 Grifols Alpha-1 Antitrypsin Drugs Basic Information
9.3.2 Grifols Alpha-1 Antitrypsin Drugs Product Overview
9.3.3 Grifols Alpha-1 Antitrypsin Drugs Product Market Performance
9.3.4 Grifols Alpha-1 Antitrypsin Drugs SWOT Analysis
9.3.5 Grifols Business Overview
9.3.6 Grifols Recent Developments
9.4 Kamada
9.4.1 Kamada Alpha-1 Antitrypsin Drugs Basic Information
9.4.2 Kamada Alpha-1 Antitrypsin Drugs Product Overview
9.4.3 Kamada Alpha-1 Antitrypsin Drugs Product Market Performance
9.4.4 Kamada Business Overview
9.4.5 Kamada Recent Developments
9.5 Abeona Therapeutics
9.5.1 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Basic Information
9.5.2 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Overview
9.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Market Performance
9.5.4 Abeona Therapeutics Business Overview
9.5.5 Abeona Therapeutics Recent Developments
9.6 Alnylam Pharmaceuticals
9.6.1 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Basic Information
9.6.2 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Overview
9.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Market Performance
9.6.4 Alnylam Pharmaceuticals Business Overview
9.6.5 Alnylam Pharmaceuticals Recent Developments
9.7 Applied Genetic Technologies Corp
9.7.1 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Basic Information
9.7.2 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Overview
9.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Market Performance
9.7.4 Applied Genetic Technologies Corp Business Overview
9.7.5 Applied Genetic Technologies Corp Recent Developments
9.8 Arrowhead Research Corporation
9.8.1 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Basic Information
9.8.2 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Overview
9.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Market Performance
9.8.4 Arrowhead Research Corporation Business Overview
9.8.5 Arrowhead Research Corporation Recent Developments
9.9 Baxalta
9.9.1 Baxalta Alpha-1 Antitrypsin Drugs Basic Information
9.9.2 Baxalta Alpha-1 Antitrypsin Drugs Product Overview
9.9.3 Baxalta Alpha-1 Antitrypsin Drugs Product Market Performance
9.9.4 Baxalta Business Overview
9.9.5 Baxalta Recent Developments
10 ALPHA-1 ANTITRYPSIN DRUGS MARKET FORECAST BY REGION
10.1 Global Alpha-1 Antitrypsin Drugs Market Size Forecast
10.2 Global Alpha-1 Antitrypsin Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Alpha-1 Antitrypsin Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size Forecast by Region
10.2.4 South America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Alpha-1 Antitrypsin Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Alpha-1 Antitrypsin Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Alpha-1 Antitrypsin Drugs by Type (2025-2030)
11.1.2 Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Alpha-1 Antitrypsin Drugs by Type (2025-2030)
11.2 Global Alpha-1 Antitrypsin Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Alpha-1 Antitrypsin Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Alpha-1 Antitrypsin Drugs Market Size Comparison by Region (M USD)
Table 5. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Alpha-1 Antitrypsin Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2022)
Table 10. Global Market Alpha-1 Antitrypsin Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Alpha-1 Antitrypsin Drugs Sales Sites and Area Served
Table 12. Manufacturers Alpha-1 Antitrypsin Drugs Product Type
Table 13. Global Alpha-1 Antitrypsin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Alpha-1 Antitrypsin Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Alpha-1 Antitrypsin Drugs Market Challenges
Table 22. Global Alpha-1 Antitrypsin Drugs Sales by Type (Kilotons)
Table 23. Global Alpha-1 Antitrypsin Drugs Market Size by Type (M USD)
Table 24. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Alpha-1 Antitrypsin Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Alpha-1 Antitrypsin Drugs Market Size Share by Type (2019-2024)
Table 28. Global Alpha-1 Antitrypsin Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) by Application
Table 30. Global Alpha-1 Antitrypsin Drugs Market Size by Application
Table 31. Global Alpha-1 Antitrypsin Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Alpha-1 Antitrypsin Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Alpha-1 Antitrypsin Drugs Market Share by Application (2019-2024)
Table 35. Global Alpha-1 Antitrypsin Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Alpha-1 Antitrypsin Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Alpha-1 Antitrypsin Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Alpha-1 Antitrypsin Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Baxter Alpha-1 Antitrypsin Drugs Basic Information
Table 44. Baxter Alpha-1 Antitrypsin Drugs Product Overview
Table 45. Baxter Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Baxter Business Overview
Table 47. Baxter Alpha-1 Antitrypsin Drugs SWOT Analysis
Table 48. Baxter Recent Developments
Table 49. CSL Behring Alpha-1 Antitrypsin Drugs Basic Information
Table 50. CSL Behring Alpha-1 Antitrypsin Drugs Product Overview
Table 51. CSL Behring Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Behring Business Overview
Table 53. CSL Behring Alpha-1 Antitrypsin Drugs SWOT Analysis
Table 54. CSL Behring Recent Developments
Table 55. Grifols Alpha-1 Antitrypsin Drugs Basic Information
Table 56. Grifols Alpha-1 Antitrypsin Drugs Product Overview
Table 57. Grifols Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Grifols Alpha-1 Antitrypsin Drugs SWOT Analysis
Table 59. Grifols Business Overview
Table 60. Grifols Recent Developments
Table 61. Kamada Alpha-1 Antitrypsin Drugs Basic Information
Table 62. Kamada Alpha-1 Antitrypsin Drugs Product Overview
Table 63. Kamada Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kamada Business Overview
Table 65. Kamada Recent Developments
Table 66. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Basic Information
Table 67. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Overview
Table 68. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Abeona Therapeutics Business Overview
Table 70. Abeona Therapeutics Recent Developments
Table 71. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Basic Information
Table 72. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Overview
Table 73. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Alnylam Pharmaceuticals Business Overview
Table 75. Alnylam Pharmaceuticals Recent Developments
Table 76. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Basic Information
Table 77. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Overview
Table 78. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Applied Genetic Technologies Corp Business Overview
Table 80. Applied Genetic Technologies Corp Recent Developments
Table 81. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Basic Information
Table 82. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Overview
Table 83. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Arrowhead Research Corporation Business Overview
Table 85. Arrowhead Research Corporation Recent Developments
Table 86. Baxalta Alpha-1 Antitrypsin Drugs Basic Information
Table 87. Baxalta Alpha-1 Antitrypsin Drugs Product Overview
Table 88. Baxalta Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Baxalta Business Overview
Table 90. Baxalta Recent Developments
Table 91. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Alpha-1 Antitrypsin Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Alpha-1 Antitrypsin Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Alpha-1 Antitrypsin Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Alpha-1 Antitrypsin Drugs Market Size Comparison by Region (M USD)
Table 5. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Alpha-1 Antitrypsin Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2022)
Table 10. Global Market Alpha-1 Antitrypsin Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Alpha-1 Antitrypsin Drugs Sales Sites and Area Served
Table 12. Manufacturers Alpha-1 Antitrypsin Drugs Product Type
Table 13. Global Alpha-1 Antitrypsin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Alpha-1 Antitrypsin Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Alpha-1 Antitrypsin Drugs Market Challenges
Table 22. Global Alpha-1 Antitrypsin Drugs Sales by Type (Kilotons)
Table 23. Global Alpha-1 Antitrypsin Drugs Market Size by Type (M USD)
Table 24. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Alpha-1 Antitrypsin Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Alpha-1 Antitrypsin Drugs Market Size Share by Type (2019-2024)
Table 28. Global Alpha-1 Antitrypsin Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) by Application
Table 30. Global Alpha-1 Antitrypsin Drugs Market Size by Application
Table 31. Global Alpha-1 Antitrypsin Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Alpha-1 Antitrypsin Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Alpha-1 Antitrypsin Drugs Market Share by Application (2019-2024)
Table 35. Global Alpha-1 Antitrypsin Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Alpha-1 Antitrypsin Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Alpha-1 Antitrypsin Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Alpha-1 Antitrypsin Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Baxter Alpha-1 Antitrypsin Drugs Basic Information
Table 44. Baxter Alpha-1 Antitrypsin Drugs Product Overview
Table 45. Baxter Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Baxter Business Overview
Table 47. Baxter Alpha-1 Antitrypsin Drugs SWOT Analysis
Table 48. Baxter Recent Developments
Table 49. CSL Behring Alpha-1 Antitrypsin Drugs Basic Information
Table 50. CSL Behring Alpha-1 Antitrypsin Drugs Product Overview
Table 51. CSL Behring Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Behring Business Overview
Table 53. CSL Behring Alpha-1 Antitrypsin Drugs SWOT Analysis
Table 54. CSL Behring Recent Developments
Table 55. Grifols Alpha-1 Antitrypsin Drugs Basic Information
Table 56. Grifols Alpha-1 Antitrypsin Drugs Product Overview
Table 57. Grifols Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Grifols Alpha-1 Antitrypsin Drugs SWOT Analysis
Table 59. Grifols Business Overview
Table 60. Grifols Recent Developments
Table 61. Kamada Alpha-1 Antitrypsin Drugs Basic Information
Table 62. Kamada Alpha-1 Antitrypsin Drugs Product Overview
Table 63. Kamada Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kamada Business Overview
Table 65. Kamada Recent Developments
Table 66. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Basic Information
Table 67. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Overview
Table 68. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Abeona Therapeutics Business Overview
Table 70. Abeona Therapeutics Recent Developments
Table 71. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Basic Information
Table 72. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Overview
Table 73. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Alnylam Pharmaceuticals Business Overview
Table 75. Alnylam Pharmaceuticals Recent Developments
Table 76. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Basic Information
Table 77. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Overview
Table 78. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Applied Genetic Technologies Corp Business Overview
Table 80. Applied Genetic Technologies Corp Recent Developments
Table 81. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Basic Information
Table 82. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Overview
Table 83. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Arrowhead Research Corporation Business Overview
Table 85. Arrowhead Research Corporation Recent Developments
Table 86. Baxalta Alpha-1 Antitrypsin Drugs Basic Information
Table 87. Baxalta Alpha-1 Antitrypsin Drugs Product Overview
Table 88. Baxalta Alpha-1 Antitrypsin Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Baxalta Business Overview
Table 90. Baxalta Recent Developments
Table 91. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Alpha-1 Antitrypsin Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Alpha-1 Antitrypsin Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Alpha-1 Antitrypsin Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Alpha-1 Antitrypsin Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Alpha-1 Antitrypsin Drugs Market Size (M USD), 2019-2030
Figure 5. Global Alpha-1 Antitrypsin Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Alpha-1 Antitrypsin Drugs Market Size by Country (M USD)
Figure 11. Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers in 2023
Figure 13. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Alpha-1 Antitrypsin Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Alpha-1 Antitrypsin Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Alpha-1 Antitrypsin Drugs Market Share by Type
Figure 18. Sales Market Share of Alpha-1 Antitrypsin Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Alpha-1 Antitrypsin Drugs by Type in 2023
Figure 20. Market Size Share of Alpha-1 Antitrypsin Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Alpha-1 Antitrypsin Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Alpha-1 Antitrypsin Drugs Market Share by Application
Figure 24. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2023
Figure 26. Global Alpha-1 Antitrypsin Drugs Market Share by Application (2019-2024)
Figure 27. Global Alpha-1 Antitrypsin Drugs Market Share by Application in 2023
Figure 28. Global Alpha-1 Antitrypsin Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Alpha-1 Antitrypsin Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Alpha-1 Antitrypsin Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2023
Figure 37. Germany Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Alpha-1 Antitrypsin Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2023
Figure 44. China Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Alpha-1 Antitrypsin Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Alpha-1 Antitrypsin Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Alpha-1 Antitrypsin Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Alpha-1 Antitrypsin Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Alpha-1 Antitrypsin Drugs Market Size (M USD), 2019-2030
Figure 5. Global Alpha-1 Antitrypsin Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Alpha-1 Antitrypsin Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Alpha-1 Antitrypsin Drugs Market Size by Country (M USD)
Figure 11. Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers in 2023
Figure 13. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Alpha-1 Antitrypsin Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Alpha-1 Antitrypsin Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Alpha-1 Antitrypsin Drugs Market Share by Type
Figure 18. Sales Market Share of Alpha-1 Antitrypsin Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Alpha-1 Antitrypsin Drugs by Type in 2023
Figure 20. Market Size Share of Alpha-1 Antitrypsin Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Alpha-1 Antitrypsin Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Alpha-1 Antitrypsin Drugs Market Share by Application
Figure 24. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2023
Figure 26. Global Alpha-1 Antitrypsin Drugs Market Share by Application (2019-2024)
Figure 27. Global Alpha-1 Antitrypsin Drugs Market Share by Application in 2023
Figure 28. Global Alpha-1 Antitrypsin Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Alpha-1 Antitrypsin Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Alpha-1 Antitrypsin Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2023
Figure 37. Germany Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Alpha-1 Antitrypsin Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2023
Figure 44. China Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Alpha-1 Antitrypsin Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Alpha-1 Antitrypsin Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Alpha-1 Antitrypsin Drugs Market Share Forecast by Application (2025-2030)
